Advertisement

Index by Author

December 1989; 38 (12)
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z

A

  1. Akashi, M

    • Effects of brief exposure to insulin-induced hypoglycemic serum during organogenesis in rat embryo culture. Diabetes December 1989 38:1573-1578; doi:10.2337/diabetes.38.12.1573

  2. Akazawa, M

    • Effects of brief exposure to insulin-induced hypoglycemic serum during organogenesis in rat embryo culture. Diabetes December 1989 38:1573-1578; doi:10.2337/diabetes.38.12.1573

  3. Akazawa, S

    • Effects of brief exposure to insulin-induced hypoglycemic serum during organogenesis in rat embryo culture. Diabetes December 1989 38:1573-1578; doi:10.2337/diabetes.38.12.1573

  4. Aronstam, R S

    • Insulin prevention of altered muscarinic receptor-G protein coupling in diabetic rat atria. Diabetes December 1989 38:1611-1616; doi:10.2337/diabetes.38.12.1611

  5. Axelrod, L

    • Prostacyclin and pathogenesis of hemodynamic abnormalities of diabetic ketoacidosis in rats. Diabetes December 1989 38:1585-1594; doi:10.2337/diabetes.38.12.1585

B

  1. Beltz, W F

    • Effects of aging on insulin secretion. Diabetes December 1989 38:1549-1556; doi:10.2337/diabetes.38.12.1549

  2. Benzi, L

    • Defects in insulin-receptor internalization and processing in monocytes of obese subjects and obese NIDDM patients. Diabetes December 1989 38:1579-1584; doi:10.2337/diabetes.38.12.1579

  3. Bergman, R N

    • Lilly lecture 1989. Toward physiological understanding of glucose tolerance. Minimal-model approach. Diabetes December 1989 38:1512-1527; doi:10.2337/diabetes.38.12.1512

  4. Blaisdell, P

    • Reduction of glycemic and lipid levels in db/db diabetic mice by psyllium plant fiber. Diabetes December 1989 38:1528-1533; doi:10.2337/diabetes.38.12.1528

  5. Blaner, W S

    • Cytoplasmic retinoid-binding proteins and retinoid effects on insulin release in RINm5F beta-cells. Diabetes December 1989 38:1544-1548; doi:10.2337/diabetes.38.12.1544

  6. Bonnevie-Nielsen, V

    • Association of IDDM and attenuated response of 2',5'-oligoadenylate synthetase to yellow fever vaccine. Diabetes December 1989 38:1636-1642; doi:10.2337/diabetes.38.12.1636

  7. Brechtel, G

    • Effects of aging on insulin secretion. Diabetes December 1989 38:1549-1556; doi:10.2337/diabetes.38.12.1549

  8. Brunetti, A

    • Defects in insulin-receptor internalization and processing in monocytes of obese subjects and obese NIDDM patients. Diabetes December 1989 38:1579-1584; doi:10.2337/diabetes.38.12.1579

C

  1. Carrier, G O

    • Insulin prevention of altered muscarinic receptor-G protein coupling in diabetic rat atria. Diabetes December 1989 38:1611-1616; doi:10.2337/diabetes.38.12.1611

  2. Caruso, M

    • Insulin regulation of lipolysis in nondiabetic and IDDM subjects. Diabetes December 1989 38:1595-1601; doi:10.2337/diabetes.38.12.1595

  3. Chao, T

    • Characterization of endothelin receptors and effects of endothelin on diacylglycerol and protein kinase C in retinal capillary pericytes. Diabetes December 1989 38:1643-1646; doi:10.2337/diabetes.38.12.1643

  4. Chertow, B S

    • Cytoplasmic retinoid-binding proteins and retinoid effects on insulin release in RINm5F beta-cells. Diabetes December 1989 38:1544-1548; doi:10.2337/diabetes.38.12.1544

  5. Chiavetta, A

    • Defects in insulin-receptor internalization and processing in monocytes of obese subjects and obese NIDDM patients. Diabetes December 1989 38:1579-1584; doi:10.2337/diabetes.38.12.1579

  6. Collins, V R

    • Prevalence and risk factors for micro- and macroalbuminuria in diabetic subjects and entire population of Nauru. Diabetes December 1989 38:1602-1610; doi:10.2337/diabetes.38.12.1602

  7. Cordle, M B

    • Cytoplasmic retinoid-binding proteins and retinoid effects on insulin release in RINm5F beta-cells. Diabetes December 1989 38:1544-1548; doi:10.2337/diabetes.38.12.1544

D

  1. D'Alessio, D A

    • Effects of glucagonlike peptide I-(7-36) on release of insulin, glucagon, and somatostatin by rat pancreatic islet cell monolayer cultures. Diabetes December 1989 38:1534-1538; doi:10.2337/diabetes.38.12.1534

  2. De Haan, M

    • Dendritic cells and scavenger macrophages in pancreatic islets of prediabetic BB rats. Diabetes December 1989 38:1623-1629; doi:10.2337/diabetes.38.12.1623

  3. Dowse, G K

    • Prevalence and risk factors for micro- and macroalbuminuria in diabetic subjects and entire population of Nauru. Diabetes December 1989 38:1602-1610; doi:10.2337/diabetes.38.12.1602

  4. Drexhage, H A

    • Dendritic cells and scavenger macrophages in pancreatic islets of prediabetic BB rats. Diabetes December 1989 38:1623-1629; doi:10.2337/diabetes.38.12.1623

  5. Duett, J

    • Erythrocyte membrane lipid peroxidation and glycosylated hemoglobin in diabetes. Diabetes December 1989 38:1539-1543; doi:10.2337/diabetes.38.12.1539

E

  1. Ensinck, J W

    • Effects of glucagonlike peptide I-(7-36) on release of insulin, glucagon, and somatostatin by rat pancreatic islet cell monolayer cultures. Diabetes December 1989 38:1534-1538; doi:10.2337/diabetes.38.12.1534

F

  1. Finch, C F

    • Prevalence and risk factors for micro- and macroalbuminuria in diabetic subjects and entire population of Nauru. Diabetes December 1989 38:1602-1610; doi:10.2337/diabetes.38.12.1602

  2. Fink, R I

    • Effects of aging on insulin secretion. Diabetes December 1989 38:1549-1556; doi:10.2337/diabetes.38.12.1549

  3. Frifelt, J J

    • Association of IDDM and attenuated response of 2',5'-oligoadenylate synthetase to yellow fever vaccine. Diabetes December 1989 38:1636-1642; doi:10.2337/diabetes.38.12.1636

  4. Fritsch, R

    • Rapid detection of IDDM susceptibility with HLA-DQ beta-alleles as markers. Diabetes December 1989 38:1617-1622; doi:10.2337/diabetes.38.12.1617

  5. Fujimoto, W Y

    • Effects of glucagonlike peptide I-(7-36) on release of insulin, glucagon, and somatostatin by rat pancreatic islet cell monolayer cultures. Diabetes December 1989 38:1534-1538; doi:10.2337/diabetes.38.12.1534

G

  1. Giorda, R

    • Rapid detection of IDDM susceptibility with HLA-DQ beta-alleles as markers. Diabetes December 1989 38:1617-1622; doi:10.2337/diabetes.38.12.1617

  2. Guerrero, J L

    • Prostacyclin and pathogenesis of hemodynamic abnormalities of diabetic ketoacidosis in rats. Diabetes December 1989 38:1585-1594; doi:10.2337/diabetes.38.12.1585

  3. Gumbiner, B

    • Effects of aging on insulin secretion. Diabetes December 1989 38:1549-1556; doi:10.2337/diabetes.38.12.1549

H

  1. Halkin, H

    • Evaluation of WHO and NDDG criteria for impaired glucose tolerance. Results from two national samples. Diabetes December 1989 38:1630-1635; doi:10.2337/diabetes.38.12.1630

  2. Harris, M I

    • Evaluation of WHO and NDDG criteria for impaired glucose tolerance. Results from two national samples. Diabetes December 1989 38:1630-1635; doi:10.2337/diabetes.38.12.1630

  3. Hashimoto, M

    • Effects of brief exposure to insulin-induced hypoglycemic serum during organogenesis in rat embryo culture. Diabetes December 1989 38:1573-1578; doi:10.2337/diabetes.38.12.1573

  4. Heiling, V

    • Insulin regulation of lipolysis in nondiabetic and IDDM subjects. Diabetes December 1989 38:1595-1601; doi:10.2337/diabetes.38.12.1595

  5. Held, M

    • Flow-cytometric detection of human anti-rat insulinoma antibodies in relation to anti-human islet cell and anti-insulin antibodies. Recognition of distinct antigens by antibodies in early type I diabetes. Diabetes December 1989 38:1557-1566; doi:10.2337/diabetes.38.12.1557

  6. Herbst, J J

    • Erythrocyte membrane lipid peroxidation and glycosylated hemoglobin in diabetes. Diabetes December 1989 38:1539-1543; doi:10.2337/diabetes.38.12.1539

  7. Hu, K Q

    • Characterization of endothelin receptors and effects of endothelin on diacylglycerol and protein kinase C in retinal capillary pericytes. Diabetes December 1989 38:1643-1646; doi:10.2337/diabetes.38.12.1643

I

  1. Iaffaldano, R

    • Prostacyclin and pathogenesis of hemodynamic abnormalities of diabetic ketoacidosis in rats. Diabetes December 1989 38:1585-1594; doi:10.2337/diabetes.38.12.1585

J

  1. Jain, S K

    • Erythrocyte membrane lipid peroxidation and glycosylated hemoglobin in diabetes. Diabetes December 1989 38:1539-1543; doi:10.2337/diabetes.38.12.1539

  2. Janeway, C A, Jr

    • Prevention of diabetes in NOD mice by injection of autoreactive T-lymphocytes. Diabetes December 1989 38:1647-1651; doi:10.2337/diabetes.38.12.1647

  3. Jensen, M D

    • Insulin regulation of lipolysis in nondiabetic and IDDM subjects. Diabetes December 1989 38:1595-1601; doi:10.2337/diabetes.38.12.1595

  4. Jeucken, P H

    • Dendritic cells and scavenger macrophages in pancreatic islets of prediabetic BB rats. Diabetes December 1989 38:1623-1629; doi:10.2337/diabetes.38.12.1623

K

  1. Kabel, P J

    • Dendritic cells and scavenger macrophages in pancreatic islets of prediabetic BB rats. Diabetes December 1989 38:1623-1629; doi:10.2337/diabetes.38.12.1623

  2. Kajinuma, H

    • Evaluation and clinical applications of measurement of urinary growth hormone in diabetic subjects. Diabetes December 1989 38:1567-1572; doi:10.2337/diabetes.38.12.1567

  3. King, G L

    • Characterization of endothelin receptors and effects of endothelin on diacylglycerol and protein kinase C in retinal capillary pericytes. Diabetes December 1989 38:1643-1646; doi:10.2337/diabetes.38.12.1643

L

  1. Lander, T

    • Flow-cytometric detection of human anti-rat insulinoma antibodies in relation to anti-human islet cell and anti-insulin antibodies. Recognition of distinct antigens by antibodies in early type I diabetes. Diabetes December 1989 38:1557-1566; doi:10.2337/diabetes.38.12.1557

  2. Larsen, M L

    • Association of IDDM and attenuated response of 2',5'-oligoadenylate synthetase to yellow fever vaccine. Diabetes December 1989 38:1636-1642; doi:10.2337/diabetes.38.12.1636

  3. Lee, T S

    • Characterization of endothelin receptors and effects of endothelin on diacylglycerol and protein kinase C in retinal capillary pericytes. Diabetes December 1989 38:1643-1646; doi:10.2337/diabetes.38.12.1643

  4. Lernmark, A

    • Association of IDDM and attenuated response of 2',5'-oligoadenylate synthetase to yellow fever vaccine. Diabetes December 1989 38:1636-1642; doi:10.2337/diabetes.38.12.1636

  5. Linnane, A W

    • Prevalence and risk factors for micro- and macroalbuminuria in diabetic subjects and entire population of Nauru. Diabetes December 1989 38:1602-1610; doi:10.2337/diabetes.38.12.1602

M

  1. McVie, R

    • Erythrocyte membrane lipid peroxidation and glycosylated hemoglobin in diabetes. Diabetes December 1989 38:1539-1543; doi:10.2337/diabetes.38.12.1539

  2. Mehnert, H

    • Flow-cytometric detection of human anti-rat insulinoma antibodies in relation to anti-human islet cell and anti-insulin antibodies. Recognition of distinct antigens by antibodies in early type I diabetes. Diabetes December 1989 38:1557-1566; doi:10.2337/diabetes.38.12.1557

  3. Michelsen, B

    • Association of IDDM and attenuated response of 2',5'-oligoadenylate synthetase to yellow fever vaccine. Diabetes December 1989 38:1636-1642; doi:10.2337/diabetes.38.12.1636

  4. Miles, J M

    • Insulin regulation of lipolysis in nondiabetic and IDDM subjects. Diabetes December 1989 38:1595-1601; doi:10.2337/diabetes.38.12.1595

  5. Miyata, H

    • Evaluation and clinical applications of measurement of urinary growth hormone in diabetic subjects. Diabetes December 1989 38:1567-1572; doi:10.2337/diabetes.38.12.1567

  6. Modan, M

    • Evaluation of WHO and NDDG criteria for impaired glucose tolerance. Results from two national samples. Diabetes December 1989 38:1630-1635; doi:10.2337/diabetes.38.12.1630

  7. Moore, M R

    • Cytoplasmic retinoid-binding proteins and retinoid effects on insulin release in RINm5F beta-cells. Diabetes December 1989 38:1544-1548; doi:10.2337/diabetes.38.12.1544

N

  1. Nagataki, S

    • Effects of brief exposure to insulin-induced hypoglycemic serum during organogenesis in rat embryo culture. Diabetes December 1989 38:1573-1578; doi:10.2337/diabetes.38.12.1573

  2. Nakanishi, T

    • Effects of brief exposure to insulin-induced hypoglycemic serum during organogenesis in rat embryo culture. Diabetes December 1989 38:1573-1578; doi:10.2337/diabetes.38.12.1573

  3. Nerl, C

    • Flow-cytometric detection of human anti-rat insulinoma antibodies in relation to anti-human islet cell and anti-insulin antibodies. Recognition of distinct antigens by antibodies in early type I diabetes. Diabetes December 1989 38:1557-1566; doi:10.2337/diabetes.38.12.1557

P

  1. Papa, V

    • Defects in insulin-receptor internalization and processing in monocytes of obese subjects and obese NIDDM patients. Diabetes December 1989 38:1579-1584; doi:10.2337/diabetes.38.12.1579

  2. Polonsky, K S

    • Effects of aging on insulin secretion. Diabetes December 1989 38:1549-1556; doi:10.2337/diabetes.38.12.1549

  3. Powell, W J, Jr

    • Prostacyclin and pathogenesis of hemodynamic abnormalities of diabetic ketoacidosis in rats. Diabetes December 1989 38:1585-1594; doi:10.2337/diabetes.38.12.1585

Q

  1. Quyyumi, A A

    • Prostacyclin and pathogenesis of hemodynamic abnormalities of diabetic ketoacidosis in rats. Diabetes December 1989 38:1585-1594; doi:10.2337/diabetes.38.12.1585

R

  1. Reich, E P

    • Prevention of diabetes in NOD mice by injection of autoreactive T-lymphocytes. Diabetes December 1989 38:1647-1651; doi:10.2337/diabetes.38.12.1647

  2. Robertson, R P

    • Type II diabetes, glucose "non-sense," and islet desensitization. Diabetes December 1989 38:1501-1505; doi:10.2337/diabetes.38.12.1501

  3. Rosen, O M

    • Banting lecture 1989. Structure and function of insulin receptors. Diabetes December 1989 38:1508-1511; doi:10.2337/diabetes.38.12.1508

  4. Ryan, C A

    • Prostacyclin and pathogenesis of hemodynamic abnormalities of diabetic ketoacidosis in rats. Diabetes December 1989 38:1585-1594; doi:10.2337/diabetes.38.12.1585

S

  1. Scaringe, D

    • Prevention of diabetes in NOD mice by injection of autoreactive T-lymphocytes. Diabetes December 1989 38:1647-1651; doi:10.2337/diabetes.38.12.1647

  2. Sherwin, R S

    • Prevention of diabetes in NOD mice by injection of autoreactive T-lymphocytes. Diabetes December 1989 38:1647-1651; doi:10.2337/diabetes.38.12.1647

  3. Standl, E

    • Flow-cytometric detection of human anti-rat insulinoma antibodies in relation to anti-human islet cell and anti-insulin antibodies. Recognition of distinct antigens by antibodies in early type I diabetes. Diabetes December 1989 38:1557-1566; doi:10.2337/diabetes.38.12.1557

  4. Suzuki, K

    • Evaluation and clinical applications of measurement of urinary growth hormone in diabetic subjects. Diabetes December 1989 38:1567-1572; doi:10.2337/diabetes.38.12.1567

  5. Suzuki, T

    • Evaluation and clinical applications of measurement of urinary growth hormone in diabetic subjects. Diabetes December 1989 38:1567-1572; doi:10.2337/diabetes.38.12.1567

T

  1. Tahara, D

    • Effects of brief exposure to insulin-induced hypoglycemic serum during organogenesis in rat embryo culture. Diabetes December 1989 38:1573-1578; doi:10.2337/diabetes.38.12.1573

  2. Trischitta, V

    • Defects in insulin-receptor internalization and processing in monocytes of obese subjects and obese NIDDM patients. Diabetes December 1989 38:1579-1584; doi:10.2337/diabetes.38.12.1579

  3. Trucco, G

    • Rapid detection of IDDM susceptibility with HLA-DQ beta-alleles as markers. Diabetes December 1989 38:1617-1622; doi:10.2337/diabetes.38.12.1617

  4. Trucco, M

    • Rapid detection of IDDM susceptibility with HLA-DQ beta-alleles as markers. Diabetes December 1989 38:1617-1622; doi:10.2337/diabetes.38.12.1617

V

  1. Vigneri, R

    • Defects in insulin-receptor internalization and processing in monocytes of obese subjects and obese NIDDM patients. Diabetes December 1989 38:1579-1584; doi:10.2337/diabetes.38.12.1579

  2. Voorbij, H A

    • Dendritic cells and scavenger macrophages in pancreatic islets of prediabetic BB rats. Diabetes December 1989 38:1623-1629; doi:10.2337/diabetes.38.12.1623

W

  1. Wallace, P

    • Effects of aging on insulin secretion. Diabetes December 1989 38:1549-1556; doi:10.2337/diabetes.38.12.1549

  2. Watters, K

    • Reduction of glycemic and lipid levels in db/db diabetic mice by psyllium plant fiber. Diabetes December 1989 38:1528-1533; doi:10.2337/diabetes.38.12.1528

  3. Wilford, M R

    • Cytoplasmic retinoid-binding proteins and retinoid effects on insulin release in RINm5F beta-cells. Diabetes December 1989 38:1544-1548; doi:10.2337/diabetes.38.12.1544

Y

  1. Yagi, J

    • Prevention of diabetes in NOD mice by injection of autoreactive T-lymphocytes. Diabetes December 1989 38:1647-1651; doi:10.2337/diabetes.38.12.1647

  2. Yamaguchi, Y

    • Effects of brief exposure to insulin-induced hypoglycemic serum during organogenesis in rat embryo culture. Diabetes December 1989 38:1573-1578; doi:10.2337/diabetes.38.12.1573

  3. Yamamoto, H

    • Effects of brief exposure to insulin-induced hypoglycemic serum during organogenesis in rat embryo culture. Diabetes December 1989 38:1573-1578; doi:10.2337/diabetes.38.12.1573

  4. Yamazaki, H

    • Effects of brief exposure to insulin-induced hypoglycemic serum during organogenesis in rat embryo culture. Diabetes December 1989 38:1573-1578; doi:10.2337/diabetes.38.12.1573

Z

  1. Zimmet, P Z

    • Prevalence and risk factors for micro- and macroalbuminuria in diabetic subjects and entire population of Nauru. Diabetes December 1989 38:1602-1610; doi:10.2337/diabetes.38.12.1602

Current Issue

  1. February 2012, 61 (2)
  1. Current Issue
  1. Alert me to new issues of Diabetes
Advertisement